News > Serum Institute to manufacture 200M doses of Covid-19 vaccine

Serum Institute to manufacture 200M doses of Covid-19 vaccine

A further collaboration among the Serum Institute of India (SII), Gavi, and the Bill and Melinda Gates Foundation will accelerate the manufacture and delivery of up to 100 million doses of safe and effective Covid-19 vaccines for India and low-and middle-income countries.

This brings the total number of vaccine doses to be covered by the partnership between SII, Gavi, and the Gates Foundation to an aggregate of up to 200 million doses.